BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Abumuaileq RRY, Abu-Assi E, López-López A, Raposeiras-Roubin S, Rodríguez-Mañero M, Martínez-Sande L, García-Seara FJ, Fernandez-López XA, González-Juanatey JR. Renal function assessment in atrial fibrillation: Usefulness of chronic kidney disease epidemiology collaboration vs re-expressed 4 variable modification of diet in renal disease. World J Cardiol 2015; 7(10): 685-694 [PMID: 26516423 DOI: 10.4330/wjc.v7.i10.685]
URL: https://www.wjgnet.com/1949-8462/full/v7/i10/685.htm
Number Citing Articles
1
Eitaro Kodani, Masaharu Akao. Atrial fibrillation and stroke prevention: state of the art—epidemiology and pathophysiology: new risk factors, concepts and controversiesEuropean Heart Journal Supplements 2020; 22(Supplement_O): O1 doi: 10.1093/eurheartj/suaa176
2
Eitaro Kodani, Hiroshi Inoue, Hirotsugu Atarashi, Hirofumi Tomita, Ken Okumura, Takeshi Yamashita, Hideki Origasa. Predictive ability of creatinine clearance versus estimated glomerular filtration rate for outcomes in patients with non-valvular atrial fibrillation: Subanalysis of the J-RHYTHM RegistryIJC Heart & Vasculature 2020; 29: 100559 doi: 10.1016/j.ijcha.2020.100559
3
Eitaro Kodani, Hirotsugu Atarashi, Hiroshi Inoue, Ken Okumura, Takeshi Yamashita, Hideki Origasa. Impact of creatinine clearance on outcomes in patients with non-valvular atrial fibrillation: a subanalysis of the J-RHYTHM RegistryEuropean Heart Journal - Quality of Care and Clinical Outcomes 2018; 4(1): 59 doi: 10.1093/ehjqcco/qcx032
4
Hirotsugu Atarashi, Shinichiro Uchiyama, Hiroshi Inoue, Takanari Kitazono, Takeshi Yamashita, Wataru Shimizu, Takanori Ikeda, Masahiro Kamouchi, Koichi Kaikita, Koji Fukuda, Hideki Origasa, Hiroaki Shimokawa. Ischemic stroke, hemorrhage, and mortality in patients with non-valvular atrial fibrillation and renal dysfunction treated with rivaroxaban: sub-analysis of the EXPAND studyHeart and Vessels 2021; 36(9): 1410 doi: 10.1007/s00380-021-01810-5